Olivia
Online
Journal for ImmunoTherapy of Cancer
@jitcancer
The official journal of @SITCancer, covering all aspects of tumor immunology and cancer immunotherapy. #JITC Editor-in-Chief: Michael T. Lotze, MD
Milwaukee, WI
Joined July 2019
1.9K Following
9.8K Followers
7.1K Posts
We're pleased to share that JITC's 2025 Impact Factor increased to 11.7, reflecting the growing reach and citation of work published in the Journal. This metric is one of several indicators of the Journal's performance and engagement. Thank you to our authors, reviewers, editors, and readers for contributing to another strong year for JITC.
Interested in cutting-edge immunology research. Explore JITC: https://t.co/y4LPi8B8aY
Access expert perspectives on significant developments in the field and address critical challenges with JITC Editor-in-Chief Dr. Michael T. Lotze's selection of recent editorials and hypotheses! The June Issue of the #JITC Digest features commentaries on recent research findings, helping readers better understand their scientific and clinical significance.
Read the Digest: https://t.co/puvx6DxufK
New #JITC article: "Tumor-derived HMGB2 induces M2-like macrophage polarization via TRIM65-mediated NLRP3 degradation to promote DLBCL progression" https://t.co/FIS12IMk6q
New #JITC article: "Targeting ATF4 overcomes dual resistance to chemo-immunotherapy in gastric cancer by disrupting the DNA damage response" https://t.co/i7H5I9Ylvl
Who to follow
Cancer Immunology Research
@CIR_AACR
Follow Cancer Immunology Research for outstanding research
across the cancer immunology discipline, accelerating effective
immunotherapies. Published by @AACR.
Society for Immunotherapy of Cancer
@sitcancer
Society for Immunotherapy of Cancer (SITC) - Dedicated to improving cancer patient outcomes by advancing the field of tumor immunology and cancer immunotherapy.
Cancer Discovery
@CD_AACR
Follow Cancer Discovery for high-impact articles and news covering major advances in basic, translational, and clinical cancer research. Published by @AACR.
New #JITC article: "CD70-targeted platform for diagnosing and treating multiple myeloma" https://t.co/CoCrIYDoma
New #JITC hypothesis: "From viral drift to tumor drift: why cancer immunotherapy needs B cells and dynamic adaptation" https://t.co/FrXTJyDGaQ
New #JITC article: "First-in-human, phase 1, open-label study of alomfilimab, an anti-ICOS antibody, as a single agent and in combination with anti-PD-L1 in advanced malignancies" https://t.co/WgYrxudYFp
@ANaingMD @Anna_Minchom
New #JITC article: "USP1-mediated lipophagy-lipogenesis axis drives cholangiocarcinoma progression and immune evasion" https://t.co/NyjstTHgf4
New #JITC article: "VSIG4 suppresses antitumor T cell immunity via the SLC3A2-dependent metabolic–ionic checkpoint" https://t.co/RlHcID6j4j
Opportunities and challenges with myeloid cells in cancer biology! Access in-depth reviews and provocative questions with a new #JITC special series, "Myeloid Cells in Immuno-Oncology", edited by Drs. Dmitry I. Gabrilovich, Jennifer L. Guerriero, and Judith A. Varner. View the full series: https://t.co/YnabkiahZc
@MyeloidNetwork
New #JITC article: "Inhibition of histone demethylase LSD1 suppresses CD47 expression and enhances efficacy of CD47 blockade in breast cancer" https://t.co/hAMu0oCTuZ
New #JITC commentary: "Targeting B7-H3 in patients with metastatic triple-negative breast cancer and brain metastases: an opportunity to “revive” immunotherapy as a treatment strategy?" https://t.co/qqPLVlYP24
@JerzakKasia @UofT_DoM
New #JITC article: "Novel CAR T cell blend targeting PDPN and GD2 to overcome glioblastoma heterogeneity" https://t.co/JQ7qVQQa4T
@FulviaFerrazzi @H_Einsele
New #JITC short report: "CD19/CD22 bivalent CAR T cells in children, adolescents and young adults with B-ALL: final phase 1 trial results" https://t.co/4IuUHz6Zbm
New #JITC article: "Systemic pre-conditioning favors effector over exhausted CD8 T-cell subsets following Sup2-IL33 armored CAR T-cell therapy" https://t.co/swV5cGkqih
@SundrudL @GeiselMed
New #JITC review: "Targeting macrophage-driven NK cell immunosuppression to improve cancer immunotherapy" https://t.co/kbF7gvZCtB
New #JITC article: "IFN-γ PET imaging stratifies and predicts response to CD137 agonism in a syngeneic colorectal tumor model" https://t.co/2URLFIrhX9
@waynestate
New #JITC letter: "Expert opinion on burning questions in cancer myeloid cell biology" https://t.co/qqxnsHSphm
@JennGuerriero @MiriamMerad @OstuniLab @megeblad @coussens_lisa
New #JITC article: "Igniting cold tumors: reprogramming the tumor immune microenvironment with dual-payload ADCs in combination with PD-L1&4-1BB bispecific antibodies" https://t.co/Uj6fnwiBP1
New #JITC article: "Spatially resolved single-cell landscape of tumor immunotypes reveals the central role of interferon signaling and plasmacytoid dendritic cells in triple-negative breast cancer" https://t.co/nKs73xzudz
@GeorgeSledge51 @BalkoLab @StoverLab @rleonferre @DrJudyBoughey
Last Seen Users on Sotwe
icon_out65
Seen from Thailand
imanmelayang🔥
Seen from Malaysia
GAY PORN POSTS
Seen from Turkey
oatttttttt(แว่นคุง)
Seen from Thailand
benim dünyam2
Seen from Turkey
🚗 CAR SEX VIDEOS 💦
john
Seen from Netherlands
Numa
Seen from United States
Alpha Couple Cuckold
Seen from Argentina
pink_fox
Seen from Turkey
Most Popular Users
Elon Musk
@elonmusk
240.3M followers
Barack Obama
@barackobama
119.3M followers
Donald J. Trump
@realdonaldtrump
111.6M followers
Cristiano Ronaldo
@cristiano
109.7M followers
Narendra Modi
@narendramodi
106.9M followers
Rihanna
@rihanna
97.5M followers
NASA
@nasa
92.1M followers
Justin Bieber
@justinbieber
90.7M followers
KATY PERRY
@katyperry
87.2M followers
Taylor Swift
@taylorswift13
81M followers
Lady Gaga
@ladygaga
72.6M followers
Kim Kardashian
@kimkardashian
69.6M followers
Virat Kohli
@imvkohli
69.2M followers
YouTube
@youtube
68.6M followers
Bill Gates
@billgates
63.6M followers
The Ellen Show
@theellenshow
62.5M followers
CNN
@cnn
61.9M followers
Neymar Jr
@neymarjr
61.9M followers
X
@x
60.9M followers
Selena Gomez
@selenagomez
60.3M followers